Skyline Medical Exhibits its STREAMWAY® System at OR Excellence Conference in Las Vegas
LAS VEGAS, Oct. 24, 2013 /PRNewswire/ -- Skyline Medical Inc. (OTCQB: SKLN) (the "Company"), formerly BioDrain Medical, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain surgical fluid disposal, today announced they will be exhibiting their technology at the OR Excellence Conference in Las Vegas, Nevada from October 24 — October 25.
The OR Excellence Conferenceis an interactive meeting for surgical facility leaders sponsored by Outpatient Surgery Magazine. Now in its fifth year, OR Excellence facilitates networking among colleagues, speakers and vendors, and helps educate conference attendees about the importance of protecting patients and employees, succeeding economically and positioning facilities for the future.
"This year, the STREAMWAY System has gone a long way to replace a competitor's product which was recently recalled for safety issues. To date, we have had numerous installations in operating rooms, hospitals and ambulatory surgical centers throughout the United States and the STREAMWAY technology has been very well received," said Josh Kornberg, Chief Executive Officer at Skyline Medical.
Kornberg continued, "We agree with the conference's focus on the value of educating operating room personnel on the importance of safety for both themselves and their patients. As such, we look forward to having discussions with the show's attendees about how the STREAMWAY System does just that by reducing healthcare workers' exposure to potentially hazardous materials and ultimately helping facilities become more efficient and environmentally friendly."
The FDA-approved STREAMWAY System is designed to improve safety and efficiency in the operating room by effectively managing surgical fluid waste disposal with its direct-to-drain technology. The STREAMWAY System virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment while dramatically decreasing costs to dispose of surgical waste. The STREAMWAY System is a stationary system designed to be installed into each surgical room that is hooked into a hospital's existing drain and vacuum system.
Skyline Medical is a corporate sponsor of the conference and will be exhibiting at Booth 216.
Skyline Medical Inc. produces a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and is not an optimal approach to the handling of surgical fluid waste. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving Occupational State and Health Association (OSHA) and other regulatory
compliance agencies' safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).
Skyline Medical's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of Skyline Medical's STREAMWAY System, the number of canisters can be significantly reduced. Skyline Medical Inc.'s STREAMWAY System is designed to make the operating room and our environment safer, cleaner, and better. Skyline Medical products are currently being represented by independent professional sales
representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.skylinemedical.com.
Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business;approximately $0.7 million in debts, liabilities and cash obligations that become due over the next twelve months;potential claims for past violations of shareholders' preemptive rights, the amount of which claims is impossible to estimate, as discussed in the Company's Form 10-Q for the quarter ended June 30, 2013;unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and
management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, as amended, and subsequent 8-K and other filings at www.sec.gov.
Public Relations Contact: Samantha Wolf KCSA Strategic Communications 212-896-1220 swolf@kcsa.com
